Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Dopamine-responsive dystonia Stories

2012-04-20 06:22:01

ATLANTA, April 20, 2012 /PRNewswire/ -- To help people learn more about the full range of symptoms associated with Parkinson's disease, global biopharmaceutical company UCB, Inc., is launching a new online community -- Parkinson's More than Motion(TM) -- that provides a platform for people living with Parkinson's disease and their caregivers to interact and learn from others with the condition. Part of this launch is the debut of a new reality-style video series depicting real families...

2012-02-07 21:11:13

UB researchers identify how the parkin gene works and how mutations cause Parkinson's disease Parkinson's disease researchers at the University at Buffalo have discovered how mutations in the parkin gene cause the disease, which afflicts at least 500,000 Americans and for which there is no cure. The UB findings reveal potential new drug targets for the disease as well as a screening platform for discovering new treatments that might mimic the protective functions of parkin. UB has...

2011-09-12 05:14:05

(Ivanhoe Newswire) — Dopamine is more than just for pleasure!  The lack of the brain chemical dopamine can rewire the interaction between two groups of brain cells and lead to symptoms of Parkinson´s disease. The discovery, made by Anatol Kreitzer, PhD, a scientist at Gladstone Institute, identified how the loss of dopamine alters the wiring of a small group of brain cells, kicking off a chain of events that eventually leads to difficulties controlling movement–a...

2011-08-25 14:08:05

Northwestern Memorial is one of the first hospitals in the country offering diagnostic test to differentiate movement disorders Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan, the only FDA-approved imaging agent for assessment of movement disorders. Until now, there were no...

2011-08-25 09:34:00

Northwestern Memorial is one of the first hospitals in the country offering diagnostic test to differentiate movement disorders CHICAGO, Aug. 25, 2011 /PRNewswire-USNewswire/ -- Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan(TM), the only FDA-approved imaging agent for assessment of...

2009-10-07 09:05:29

A Michigan hospital is embarking on a research study for advanced Parkinson's disease using a state-of-the-art treatment called gene transfer. The clinical trial will test whether gene transfer therapy is able to restore better mobility in Parkinson's patients who have lost responsiveness to drug therapy. "The start of this clinical trial provides hope to a Parkinson's disease patient population that has had a long-standing need for better treatment options," says Henry Ford West Bloomfield...

2009-10-06 14:07:00

WEST BLOOMFIELD, Mich., Oct. 6 /PRNewswire/ -- Henry Ford West Bloomfield Hospital is embarking on a research study for advanced Parkinson's disease using a state-of-the-art treatment called gene transfer. The clinical trial will test whether gene transfer therapy is able to restore better mobility in Parkinson's patients who have lost responsiveness to drug therapy. "The start of this clinical trial provides hope to a Parkinson's disease patient population that has had a...

2009-09-02 13:39:01

University of Florida scientists say they've found a common antibiotic can become an off switch for a gene therapy being developed for Parkinson's disease. The scientists, led by Professor Ronald Mandel, said their discovery made during a study involving rats answers an important question -- how can new, therapeutic genes that have been irrevocably delivered to the human brain to treat Parkinson's be controlled if the genes unexpectedly start causing problems? The researchers also said prior...

2009-08-11 16:45:29

U.S. scientists have found a second brain lesion prevents dystonia in people who already have a lesion due to a genetic mutation for the movement disorder. Researchers at the Feinstein Institute for Medical Research, Weill Cornell Medical College and the Beth Israel Medical Center used a type of magnetic resonance imaging to study the integrity of nerve pathways in the brains of 20 people with dystonia -- a disorder characterized by sustained involuntary muscle contractions. Although all 20...

2009-08-05 11:28:43

 Most people who carry a genetic mutation for a movement disorder called dystonia will never develop symptoms, a phenomenon that has puzzled scientists since the first genetic mutation was identified in the 1990's. Now, scientists at The Feinstein Institute for Medical Research have figured out why these mutation carriers are protected from symptoms of the disorder "“ they have an additional lesion that evens the score.Dystonia is marked by uncontrolled movements, particularly...